Bnp Paribas Asset Management Holding S.A. Harmony Biosciences Holdings, Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 363 shares of HRMY stock, worth $10,490. This represents 0.0% of its overall portfolio holdings.
Number of Shares
363Holding current value
$10,490% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HRMY
# of Institutions
290Shares Held
46.3MCall Options Held
316KPut Options Held
69.9K-
Valor Management LLC Chicago, IL6.62MShares$191 Million88.32% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$169 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$148 Million0.0% of portfolio
-
State Street Corp Boston, MA1.63MShares$47.1 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.58MShares$45.7 Million0.01% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.71B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...